Connection

Solange Peters to Prognosis

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Prognosis.
Solange Peters
Connection Strength
0.076
Prognosis
  1. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial. J Thorac Oncol. 2017 04; 12(4):752-762.
    View in: PubMed
    Score: 0.031
  2. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 06 20; 395(10241):1907-1918.
    View in: PubMed
    Score: 0.010
  3. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol. 2020 07; 15(7):1119-1136.
    View in: PubMed
    Score: 0.010
  4. Brain metastases. Nat Rev Dis Primers. 2019 01 17; 5(1):5.
    View in: PubMed
    Score: 0.009
  5. Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort. J Thorac Oncol. 2018 12; 13(12):1851-1863.
    View in: PubMed
    Score: 0.009
  6. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Lung Cancer. 2017 09; 111:143-149.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.